載入...
Methylene blue treatment delays progression of perfusion-diffusion mismatch to infarct in permanent ischemic stroke
Stroke is a leading cause of morbidity and mortality in the world. Low-dose methylene blue (MB), which has been used safely to treat methemoglobinemia and cyanide poisoning in humans, has energy enhancing and antioxidant properties. We tested the hypothesis that methylene blue treatment delays progr...
Na minha lista:
| 發表在: | Brain Res |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907336/ https://ncbi.nlm.nih.gov/pubmed/25218555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2014.09.007 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|